Table 2.
The characteristics of the study population.
| Variables * | All Patients | Mild Disease (n = 180) | Moderate Disease (n = 143) |
Severe Disease (n = 43) | p-Value |
|---|---|---|---|---|---|
| Age | 54.48 ± 16.48 | 53.86 ± 17.46 | 57.51 ± 12.89 | 54.35 ± 16.18 | 0.43 |
| Gender | |||||
| Male | 219 | 101 (56%) | 91 (64%) | 27 (63%) | 0.36 |
| Female | 147 | 79 (44%) | 52 (36%) | 16 (37%) | |
| WBC | 7.49 [7.15–7.83] | 6.77 [6.38–7.26] | 8.08 [7.60–8.73] | 7.98 [7.50–8.42] | <0.001 |
| Platelets | 238.25 [230.93–243.69] |
231.70 [220-.95–240.22] |
243.20 [221.87–265.52] |
245 [236.51–259.56] |
0.11 |
| Neutrophils | 4.42 [4.22–4.69] | 3.80 [3.44–4.25] | 4.68 [4.39–5.26] | 4.96 [4.57–5.45] | <0.001 |
| Lymphocytes | 2.10 [1.97–2.23] | 2.22 [1.99–2.30] | 2.16 [1.91–2.34] | 1.97 [1.79–2.20] | 0.12 |
| Monocytes | 0.51 [0.48–0.53] | 0.49 [0.45–0.52] | 0.52 [0.47–0.56] | 0.53 [0.48–0.57] | 0.59 |
| PLR | 114.96 [110.45–121.10] |
108.07 [100.89–115.10] |
110.75 [96.66–126.26] |
129.79 [117.02–135.15] |
0.002 |
| NLR | 2.05 [1.90–2.19] | 1.73 [1.59–1.88] | 2.23 [1.93–2.66] | 2.53 [2.20–2.79] | <0.001 |
| d-NLR | 1.55 [1.44–1.65] | 1.37 [1.29–1.49] | 1.45 [1.36–1.82] | 1.80 [1.62–1.95] | 0.001 |
| MLR | 0.23 [0.22–0.25] | 0.22 [0.21–0.25] | 0.25 [0.23–0.28] | 0.24 [0.22–0.26] | 0.04 |
| PMR | 475.02 [450.39–508.40] |
479.08 [440.36–526.90] |
467.59 [400–539.75] |
476.42 [437.62–524.45] |
0.75 |
| SII | 478.52 [453.65–521.85] |
404.61 [357.44–446.03] |
541.21 [464.89–602.06] |
560.46 [518.95–646.30] |
<0.001 |
| SIRI | 1.03 [0.93–1.09] | 0.86 [0.79–0.92] | 1.23 [1.01–1.44] | 1.27 [1.07–1.37] | 0.001 |
| AISI | 255.83 [229–273.18] |
196.96 [168.52–221.22] |
287.76 [258.18–331.08] |
293.10 [272.01–335.63] |
0.001 |
| ESR | 15 [12.8–17] |
12.80 [11.80–15.80] |
16.20 [12.20–20.98] |
18 [14–20] |
0.17 |
WBC, white blood cell count; PLR, platelet-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; d-NLR, derived neutrophil-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio; PMR, platelet-to-monocyte ratio; SII, systemic immune inflammation index; SIRI, systemic inflammation response index; AISI, aggregate index of systemic inflammation; ESR, erythrocyte sedimentation rate; * refer to Table 1 for measurement units.